These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17689538)

  • 21. Tibolone and risk of endometrial polyps: a prospective, comparative study with hormone therapy.
    Perez-Medina T; Bajo-Arenas J; Haya J; Sanfrutos L; Iniesta S; Bueno B; Castelo-Branco C
    Menopause; 2003; 10(6):534-7. PubMed ID: 14627862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tibolone and the promise of ideal hormone-replacement therapy.
    El-Hajj Fuleihan G
    N Engl J Med; 2008 Aug; 359(7):753-5. PubMed ID: 18703480
    [No Abstract]   [Full Text] [Related]  

  • 23. Pros and cons of existing treatment modalities in osteoporosis: a comparison between tibolone, SERMs and estrogen (+/-progestogen) treatments.
    Kloosterboer HJ; Ederveen AG
    J Steroid Biochem Mol Biol; 2002 Dec; 83(1-5):157-65. PubMed ID: 12650712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women.
    Dahm AE; Eilertsen AL; Goeman J; Olstad OK; Ovstebø R; Kierulf P; Mowinckel MC; Skretting G; Sandset PM
    Thromb Res; 2012 Jul; 130(1):45-51. PubMed ID: 22217510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytohormonal and morphological alterations in cervicovaginal smears of postmenopausal women on hormone replacement therapy.
    Gupta S; Kumar N; Singhal N; Manektala U; Jain S; Sodhani P
    Diagn Cytopathol; 2006 Oct; 34(10):676-81. PubMed ID: 16955474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can keratin 8 and 17 immunohistochemistry be of diagnostic value in cervical cytology? A feasibility study.
    Martens J; Baars J; Smedts F; Holterheus M; Kok MJ; Vooijs P; Ramaekers F
    Cancer; 1999 Apr; 87(2):87-92. PubMed ID: 10227599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of hormone therapy, tibolone and raloxifene on circulating vascular endothelial growth factor in Greek postmenopausal women.
    Christodoulakos G; Lambrinoudaki I; Panoulis C; Papadias C; Sarandakou A; Liakakos T; Alexandrou A; Creatsas G
    Eur J Endocrinol; 2004 Aug; 151(2):187-92. PubMed ID: 15296473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of low dose of tibolone on steroid receptors and Bcl-2 on the postmenopausal endometrium.
    Reis BF; Lima SM; Silva GM; Francisco AM; Barbosa LC; Archangelo SC; Grande RM
    Histol Histopathol; 2016 Jun; 31(6):629-34. PubMed ID: 26670665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Reasons for abandonment of hormone replacement therapy with tibolone in menopausal women].
    Zayas-Jaime FJ; Ornelas-Aguirre JM; Pérez-Nápoles DE
    Ginecol Obstet Mex; 2013 Oct; 81(10):593-601. PubMed ID: 24483042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Relation between hormonal therapy and tibolone with SERMs in postmenopausal women's myomes growth].
    Carranza Lira S
    Ginecol Obstet Mex; 2008 Oct; 76(10):610-4. PubMed ID: 19062511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of tibolone in older postmenopausal women.
    Cummings SR; Ettinger B; Delmas PD; Kenemans P; Stathopoulos V; Verweij P; Mol-Arts M; Kloosterboer L; Mosca L; Christiansen C; Bilezikian J; Kerzberg EM; Johnson S; Zanchetta J; Grobbee DE; Seifert W; Eastell R;
    N Engl J Med; 2008 Aug; 359(7):697-708. PubMed ID: 18703472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.
    Ziaei S; Moghasemi M; Faghihzadeh S
    Climacteric; 2010 Apr; 13(2):147-56. PubMed ID: 19731119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of conventional and low dose oral hormone therapy (HT), tibolone, and raloxifene on coagulation and fibrinolysis.
    Eilertsen AL; Sandvik L; Mowinckel MC; Andersen TO; Qvigstad E; Sandset PM
    Thromb Res; 2007; 120(3):371-9. PubMed ID: 17156824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tibolone treatment of diabetic postmenopausal women: clinical and laboratory safety parameters].
    Freitas AK; Freitas RA; Prado MF; Azevedo GD; Foss MC; Silva-de-Sá MF; Ferriani RA
    Arq Bras Endocrinol Metabol; 2005 Jun; 49(3):433-40. PubMed ID: 16543999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormone replacement therapy dependent changes in breast cancer-related gene expression in breast tissue of healthy postmenopausal women.
    Sieuwerts AM; De Napoli G; van Galen A; Kloosterboer HJ; de Weerd V; Zhang H; Martens JW; Foekens JA; De Geyter C
    Mol Oncol; 2011 Dec; 5(6):504-16. PubMed ID: 21956102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endometrial adenocarcinoma after prolonged tibolone therapy.
    Nassar AH; Khalil AM; Seoud MA; Usta IM
    Int J Gynaecol Obstet; 2005 Jul; 90(1):78-9. PubMed ID: 15913616
    [No Abstract]   [Full Text] [Related]  

  • 37. Parity is associated with lower cervical E-cadherin expression in postmenopausal women.
    Sioulas V; Lambrinoudaki I; Politi E; Kyroudi A; Sergentanis TN; Panoulis C; Augoulea A; Kaparos G; Creatsa M; Koutselini H; Papadias K
    J Obstet Gynaecol Res; 2008 Dec; 34(6):1043-8. PubMed ID: 19012706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of hormone replacement therapy and tibolone on skin thickness and bone in postmenopausal women.
    Demir B; Adabag A; Ozturk N; Gunes M
    Ann Saudi Med; 2006; 26(2):161-2. PubMed ID: 16761464
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: a double-blind, randomised study.
    Polisseni AF; Andrade AT; Ribeiro LC; Castro IQ; Brandão M; Polisseni F; Guerra Mde O
    Maturitas; 2013 Feb; 74(2):172-8. PubMed ID: 23201326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are biannual Papanicolaou (Pap) tests useful in postmenopausal women? Does hormone replacement therapy (HRT) affect the development of cervical cytology abnormalities?
    Nguyen D; Church L
    J Fam Pract; 2001 Apr; 50(4):368. PubMed ID: 11300991
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.